Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
In millions, except per share items | Feb-28-18 | Nov-30-17 | Aug-31-17 | May-31-17 | Feb-28-17 | Nov-30-16 | Aug-31-16 | May-31-16 |
| 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K | 10-Q |
Revenues: |
Seeds and Genomics | 4,088.0 | 1,770.0 | 1,747.0 | 3,132.0 | 4,186.0 | 1,848.0 | 1,565.0 | 3,207.0 |
Agricultural Productivity | 931.0 | 888.0 | 939.0 | 1,098.0 | 888.0 | 802.0 | 997.0 | 982.0 |
Total revenues | 5,019.0 | 2,658.0 | 2,686.0 | 4,230.0 | 5,074.0 | 2,650.0 | 2,562.0 | 4,189.0 |
Revenue growth [+] | -1.1% | 0.3% | 4.8% | 1.0% | 12.0% | 19.4% | 8.8% | -8.5% |
Seeds and Genomics | -2.3% | -4.2% | 11.6% | -2.3% | 9.7% | 32.1% | 25.1% | 0.4% |
Agricultural Productivity | 4.8% | 10.7% | -5.8% | 11.8% | 24.2% | -2.2% | -9.7% | -29.1% |
Cost of goods sold | 2,053.0 | 1,346.0 | 1,346.0 | 1,844.0 | 2,122.0 | 1,391.0 | 1,424.0 | 1,809.0 |
Gross profit | 2,966.0 | 1,312.0 | 1,340.0 | 2,386.0 | 2,952.0 | 1,259.0 | 1,138.0 | 2,380.0 |
Gross margin | 59.1% | 49.4% | 49.9% | 56.4% | 58.2% | 47.5% | 44.4% | 56.8% |
Selling, general and administrative [+] | 652.0 | 664.0 | 938.0 | 789.0 | 657.0 | 585.0 | 975.0 | 729.0 |
General and administrative | | | 938.0 | | | | 975.0 | |
Research and development | 394.0 | 382.0 | 439.0 | 417.0 | 381.0 | 370.0 | 421.0 | 387.0 |
EBITDA [+] | 2,113.0 | 454.0 | 162.0 | 1,357.0 | 2,097.0 | 493.0 | -73.0 | 1,442.0 |
EBITDA growth | 0.8% | -7.9% | -321.9% | -5.9% | 13.0% | 181.7% | -763.6% | -20.8% |
EBITDA margin | 42.1% | 17.1% | 6.0% | 32.1% | 41.3% | 18.6% | -2.8% | 34.4% |
Depreciation | 162.0 | 165.0 | 165.0 | 125.0 | 155.0 | 159.0 | 157.0 | 149.0 |
EBITA | 1,951.0 | 289.0 | -3.0 | 1,232.0 | 1,942.0 | 334.0 | -230.0 | 1,293.0 |
EBITA margin | 38.9% | 10.9% | -0.1% | 29.1% | 38.3% | 12.6% | -9.0% | 30.9% |
Amortization of intangibles | 31.0 | 23.0 | 34.0 | 52.0 | 28.0 | 30.0 | 28.0 | 29.0 |
EBIT [+] | 1,920.0 | 266.0 | -37.0 | 1,180.0 | 1,914.0 | 304.0 | -258.0 | 1,264.0 |
EBIT growth | 0.3% | -12.5% | -85.7% | -6.6% | 14.5% | -5166.7% | 54.5% | -23.1% |
EBIT margin | 38.3% | 10.0% | -1.4% | 27.9% | 37.7% | 11.5% | -10.1% | 30.2% |
Non-recurring items | 24.0 | 24.0 | 26.0 | 16.0 | 50.0 | 57.0 | 7.0 | 15.0 |
Interest expense, net [+] | 81.0 | 109.0 | 91.0 | 83.0 | 84.0 | 118.0 | 81.0 | 86.0 |
Interest expense | 105.0 | 124.0 | 114.0 | 100.0 | 102.0 | 136.0 | 104.0 | 100.0 |
Interest income | 24.0 | 15.0 | 23.0 | 17.0 | 18.0 | 18.0 | 23.0 | 14.0 |
Other income (expense), net | 24.0 | 97.0 | 9.0 | -4.0 | 88.0 | -43.0 | 138.0 | 35.0 |
Pre-tax income | 1,839.0 | 230.0 | -145.0 | 1,077.0 | 1,868.0 | 86.0 | -208.0 | 1,198.0 |
Income taxes | 381.0 | 60.0 | -170.0 | 230.0 | 505.0 | 61.0 | -1.0 | 483.0 |
Tax rate | 20.7% | 26.1% | 117.2% | 21.4% | 27.0% | 70.9% | 0.5% | 40.3% |
Minority interest | 1.0 | 2.0 | 5.0 | 4.0 | -2.0 | 6.0 | -14.0 | -2.0 |
Earnings from continuing ops | 1,457.0 | 168.0 | 20.0 | 843.0 | 1,365.0 | 19.0 | -193.0 | 717.0 |
Earnings from discontinued ops | 2.0 | 1.0 | | | 3.0 | 10.0 | 2.0 | |
Net income | 1,459.0 | 169.0 | 20.0 | 843.0 | 1,368.0 | 29.0 | -191.0 | 717.0 |
Net margin | 29.1% | 6.4% | 0.7% | 19.9% | 27.0% | 1.1% | -7.5% | 17.1% |
|
Basic EPS [+] | $3.30 | $0.38 | $0.05 | $1.92 | $3.11 | $0.04 | ($0.44) | $1.64 |
Growth | 6.2% | 780.0% | -110.5% | 17.0% | 28.7% | -103.7% | -58.4% | -32.0% |
Diluted EPS [+] | $3.27 | $0.38 | $0.05 | $1.90 | $3.09 | $0.04 | ($0.43) | $1.63 |
Growth | 6.0% | 777.1% | -110.4% | 16.8% | 28.6% | -103.7% | -58.4% | -31.9% |
|
Dividends per share [+] | $1.08 | $0.54 | $1.08 | $0.54 | $1.08 | $0.54 | $1.08 | $0.54 |
Growth | 0.0% | -0.1% | 0.0% | 0.0% | 0.0% | -3.3% | 4.9% | -100.0% |
|
Shares outstanding (basic) [+] | 441.0 | 440.2 | 438.8 | 439.1 | 438.7 | 438.1 | 442.7 | 437.1 |
Growth | 0.5% | 0.5% | -0.9% | 0.5% | 0.0% | -3.5% | -7.2% | -7.6% |
Shares outstanding (diluted) [+] | 445.5 | 445.3 | 443.8 | 443.4 | 442.3 | 441.7 | 447.1 | 440.3 |
Growth | 0.7% | 0.8% | -0.7% | 0.7% | 0.1% | -2.7% | -7.1% | -7.7% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|